Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Ottawa, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The global next-generation sequencing market size is projected to grow from USD 14.25 billion in 2025 to approximately USD 103.24 billion by 2035, at a CAGR...
-
NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Vistagen Therapeutics, Inc. (NASDAQ: VTGN). Shareholders who purchased shares of VTGN...
-
SPRINGFIELD, Mo., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Great Southern Bancorp, Inc. (the “Company”) (NASDAQ:GSBC), the holding company for Great Southern Bank (the “Bank”), today reported that...
-
St. Petersburg, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Raymond James Financial, Inc. (NYSE: RJF) announced today its expected earnings release dates and conference call information for the first,...
-
Raul Vazquez to step down as CEO and Board member no later than April 3, 2026Board initiates CEO searchProvides preliminary fourth quarter and full year 2025 financial and operating results SAN...
-
ATHENS, Greece, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Capital Clean Energy Carriers Corp. (the “Company”, “CCEC,” “we” or “us”) (NASDAQ: CCEC), an international owner of ocean-going vessels, today...
-
Amsterdam, January 21, 2026 SBM Offshore reports the transaction details related to its EUR141 million (c. US$150 million1) share repurchase program for the period January 15, 2026 through January...
-
CT United FC Unveils the 2026 Season Schedule, Season Ticket Deposits, and Inaugural Roster Signings
BRIDGEPORT, Conn., Jan. 21, 2026 (GLOBE NEWSWIRE) -- CT United FC, a new professional men’s soccer club set to compete in MLS NEXT Pro, announced several foundational milestones as preparations...
-
ESO appoints two senior executives as the company accelerates its mission to improve emergency response outcomes through data intelligence.
-
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101)